{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T10:28:16Z","timestamp":1781519296431,"version":"3.54.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,4,21]],"date-time":"2013-04-21T00:00:00Z","timestamp":1366502400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1007\/s12185-013-1339-3","type":"journal-article","created":{"date-parts":[[2013,4,20]],"date-time":"2013-04-20T05:16:59Z","timestamp":1366435019000},"page":"624-633","source":"Crossref","is-referenced-by-count":22,"title":["Establishment of a CD4-positive cell line from an AIDS-related primary effusion lymphoma"],"prefix":"10.1007","volume":"97","author":[{"given":"Hiroki","family":"Goto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,21]]},"reference":[{"key":"1339_CR1","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood.V88.2.645.bloodjournal882645","volume":"88","author":"RG Nador","year":"1996","unstructured":"Nador RG, Cesarman E, Chadburn A, Dawson DB, Ansari MQ, Sald J, et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi\u2019s sarcoma-associated herpes virus. Blood. 1996;88:645\u201356.","journal-title":"Blood"},{"key":"1339_CR2","doi-asserted-by":"crossref","first-page":"8218","DOI":"10.1128\/JVI.70.11.8218-8223.1996","volume":"70","author":"E Cesarman","year":"1996","unstructured":"Cesarman E, Nador RG, Bai F, Bohenzky RA, Russo JJ, Moore PS, et al. Kaposi\u2019s sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi\u2019s sarcoma and malignant lymphoma. J Virol. 1996;70:8218\u201323.","journal-title":"J Virol"},{"key":"1339_CR3","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199505043321802","volume":"332","author":"E Cesarman","year":"1995","unstructured":"Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi\u2019s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. New Eng J Med. 1995;332:1186\u201391.","journal-title":"New Eng J Med"},{"key":"1339_CR4","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1365-2141.1997.00064.x","volume":"97","author":"A Carbone","year":"1997","unstructured":"Carbone A, Gaidano G. HHV-8-positive body-cavity-based lymphoma: a novel lymphoma entity. Br J Haematol. 1997;97:515\u201322.","journal-title":"Br J Haematol"},{"key":"1339_CR5","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/ijc.10086","volume":"97","author":"R Merat","year":"2002","unstructured":"Merat R, Amara A, Lebbe C, de The H, Morel P, Saib A. HIV-1 infection of primary effusion lymphoma cell line triggers Kaposi\u2019s sarcoma-associated herpesvirus (KSHV) reactivation. Int J Cancer. 2002;97:791\u20135.","journal-title":"Int J Cancer"},{"key":"1339_CR6","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jmb.2011.03.055","volume":"410","author":"X Zhu","year":"2011","unstructured":"Zhu X, Zhou F, Qin D, Zeng Y, Lv Z, Yao S, et al. Human immunodeficiency virus type 1 induces lytic cycle replication of Kaposi\u2019s-sarcoma-associated herpesvirus: role of Ras\/c-Raf\/MEK1\/2, PI3\u00a0K\/AKT, and NF-kappaB signaling pathways. J Mol Biol. 2011;410:1035\u201351.","journal-title":"J Mol Biol"},{"key":"1339_CR7","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/sj.leu.2401428","volume":"13","author":"HG Drexler","year":"1999","unstructured":"Drexler HG, Matsuo Y. Guidelines for the characterization and publication of human malignant hematopoietic cell lines. Leukemia. 1999;13:835\u201342.","journal-title":"Leukemia"},{"key":"1339_CR8","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nm0396-342","volume":"2","author":"R Renne","year":"1996","unstructured":"Renne R, Zhong W, Herndier B, McGrath M, Abbey N, Kedes D, et al. Lytic growth of Kaposi\u2019s sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med. 1996;2:342\u20136.","journal-title":"Nat Med"},{"key":"1339_CR9","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1182\/blood.V86.7.2708.2708","volume":"86","author":"E Cesarman","year":"1995","unstructured":"Cesarman E, Moore PS, Rao PH, Inghirami G, Knowles DM, Chang Y. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi\u2019s sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood. 1995;86:2708\u201314.","journal-title":"Blood"},{"key":"1339_CR10","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1182\/blood.V88.7.2648.bloodjournal8872648","volume":"88","author":"L Arvanitakis","year":"1996","unstructured":"Arvanitakis L, Mesri EA, Nador RG, Said JW, Asch AS, Knowles DM, et al. Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring kaposi\u2019s sarcoma-associated herpesvirus (KSHV\/HHV-8) in the absence of Epstein-Barr virus. Blood. 1996;88:2648\u201354.","journal-title":"Blood"},{"key":"1339_CR11","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/(SICI)1096-9071(199908)58:4<394::AID-JMV12>3.0.CO;2-H","volume":"58","author":"H Katano","year":"1999","unstructured":"Katano H, Hoshino Y, Morishita Y, Nakamura T, Satoh H, Iwamoto A, et al. Establishing and characterizing a CD30-positive cell line harboring HHV-8 from a primary effusion lymphoma. J Med Virol. 1999;58:394\u2013401.","journal-title":"J Med Virol"},{"key":"1339_CR12","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0140-6736(64)92345-1","volume":"1","author":"JV Pulvertaft","year":"1964","unstructured":"Pulvertaft JV. Cytology of Burkitt\u2019s Tumour (African Lymphoma). Lancet. 1964;1:238\u201340.","journal-title":"Lancet"},{"key":"1339_CR13","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1182\/blood.V91.5.1671.1671_1671_1679","volume":"91","author":"C Boshoff","year":"1998","unstructured":"Boshoff C, Gao SJ, Healy LE, Matthews S, Thomas AJ, Coignet L, et al. Establishing a KSHV\u00a0+\u00a0cell line (BCP-1) from peripheral blood and characterizing its growth in Nod\/SCID mice. Blood. 1998;91:1671\u20139.","journal-title":"Blood"},{"key":"1339_CR14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF02982580","volume":"76","author":"J Miyagi","year":"2002","unstructured":"Miyagi J, Masuda M, Takasu N, Nagasaki A, Shinjyo T, Uezato H, et al. Establishment of a primary effusion lymphoma cell line (RM-P1) and in vivo growth system using SCID mice. Int J Hematol. 2002;76:165\u201372.","journal-title":"Int J Hematol"},{"key":"1339_CR15","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1128\/JVI.71.1.314-324.1997","volume":"71","author":"G Miller","year":"1997","unstructured":"Miller G, Heston L, Grogan E, Gradoville L, Rigsby M, Sun R, et al. Selective switch between latency and lytic replication of Kaposi\u2019s sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells. J Virol. 1997;71:314\u201324.","journal-title":"J Virol"},{"key":"1339_CR16","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1182\/blood-2004-09-3569","volume":"105","author":"CM Klass","year":"2005","unstructured":"Klass CM, Krug LT, Pozharskaya VP, Offermann MK. The targeting of primary effusion lymphoma cells for apoptosis by inducing lytic replication of human herpesvirus 8 while blocking virus production. Blood. 2005;105:4028\u201334.","journal-title":"Blood"},{"key":"1339_CR17","volume-title":"ISCN 2005: an international system for human cytogenetic nomenclature (2005): recommendations of the International Standing Committee on Human Cytogenetic Nomenclature","author":"LG Shaffer","year":"2005","unstructured":"Shaffer LG, Tommerup N, International Standing Committee on Human Cytogenetic Nomenclature. ISCN 2005: an international system for human cytogenetic nomenclature (2005): recommendations of the International Standing Committee on Human Cytogenetic Nomenclature. Basel: Karger; 2005."},{"key":"1339_CR18","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1349-7006.1990.tb02561.x","volume":"81","author":"H Uhara","year":"1990","unstructured":"Uhara H, Sato Y, Mukai K, Akao I, Matsuno Y, Furuya S, et al. Detection of Epstein-Barr virus DNA in Reed-Sternberg cells of Hodgkin\u2019s disease using the polymerase chain reaction and in situ hybridization. Jap J Cancer Res: Gann. 1990;81:272\u20138.","journal-title":"Jap J Cancer Res: Gann"},{"key":"1339_CR19","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1128\/JVI.78.7.3601-3620.2004","volume":"78","author":"HH Krishnan","year":"2004","unstructured":"Krishnan HH, Naranatt PP, Smith MS, Zeng L, Bloomer C, Chandran B. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi\u2019s sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression. J Virol. 2004;78:3601\u201320.","journal-title":"J Virol"},{"key":"1339_CR20","doi-asserted-by":"crossref","first-page":"10138","DOI":"10.1128\/JVI.79.16.10138-10146.2005","volume":"79","author":"J Bechtel","year":"2005","unstructured":"Bechtel J, Grundhoff A, Ganem D. RNAs in the virion of Kaposi\u2019s sarcoma-associated herpesvirus. J Virol. 2005;79:10138\u201346.","journal-title":"J Virol"},{"key":"1339_CR21","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/sj.bjc.6604539","volume":"99","author":"K Ota","year":"2008","unstructured":"Ota K, Fujimori H, Ueda M, Shiniriki S, Kudo M, Jono H, et al. Midkine as a prognostic biomarker in oral squamous cell carcinoma. Br J Cancer. 2008;99:655\u201362.","journal-title":"Br J Cancer"},{"key":"1339_CR22","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.3646751","volume":"236","author":"Y Koyanagi","year":"1987","unstructured":"Koyanagi Y, Miles S, Mitsuyasu RT, Merrill JE, Vinters HV, Chen IS. Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science. 1987;236:819\u201322.","journal-title":"Science"},{"key":"1339_CR23","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1349-7006.2012.02212.x","volume":"103","author":"H Goto","year":"2012","unstructured":"Goto H, Kariya R, Shimamoto M, Kudo E, Taura M, Katano H, et al. Antitumor effect of berberine against primary effusion lymphoma via inhibition of NF-kappaB pathway. Cancer Sci. 2012;103:775\u201381.","journal-title":"Cancer Sci"},{"key":"1339_CR24","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/sj.leu.2401160","volume":"12","author":"HG Drexler","year":"1998","unstructured":"Drexler HG, Uphoff CC, Gaidano G, Carbone A. Lymphoma cell lines: in vitro models for the study of HHV-8+ primary effusion lymphomas (body cavity-based lymphomas). Leukemia. 1998;12:1507\u201317.","journal-title":"Leukemia"},{"key":"1339_CR25","doi-asserted-by":"crossref","first-page":"10866","DOI":"10.1073\/pnas.95.18.10866","volume":"95","author":"R Sun","year":"1998","unstructured":"Sun R, Lin SF, Gradoville L, Yuan Y, Zhu F, Miller G. A viral gene that activates lytic cycle expression of Kaposi\u2019s sarcoma-associated herpesvirus. Proc Natl Acad Sci USA. 1998;95:10866\u201371.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1339_CR26","doi-asserted-by":"crossref","first-page":"9348","DOI":"10.1128\/JVI.73.11.9348-9361.1999","volume":"73","author":"DM Lukac","year":"1999","unstructured":"Lukac DM, Kirshner JR, Ganem D. Transcriptional activation by the product of open reading frame 50 of Kaposi\u2019s sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells. J Virol. 1999;73:9348\u201361.","journal-title":"J Virol"},{"key":"1339_CR27","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0140-6736(91)92513-2","volume":"337","author":"V Beral","year":"1991","unstructured":"Beral V, Peterman T, Berkelman R, Jaffe H. AIDS-associated non-Hodgkin lymphoma. Lancet. 1991;337:805\u20139.","journal-title":"Lancet"},{"key":"1339_CR28","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1182\/blood-2008-09-180315","volume":"113","author":"A Carbone","year":"2009","unstructured":"Carbone A, Cesarman E, Spina M, Gloghini A, Schulz TF. HIV-associated lymphomas and gamma-herpesviruses. Blood. 2009;113:1213\u201324.","journal-title":"Blood"},{"key":"1339_CR29","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1128\/JVI.74.8.3478-3485.2000","volume":"74","author":"H Katano","year":"2000","unstructured":"Katano H, Iwasaki T, Baba N, Terai M, Mori S, Iwamoto A, et al. Identification of antigenic proteins encoded by human herpesvirus 8 and seroprevalence in the general population and among patients with and without Kaposi\u2019s sarcoma. J Virol. 2000;74:3478\u201385.","journal-title":"J Virol"},{"key":"1339_CR30","first-page":"137","volume":"53","author":"H Katano","year":"2000","unstructured":"Katano H, Sata T. Human herpesvirus 8 virology, epidemiology and related diseases. Jpn J Infect Dis. 2000;53:137\u201355.","journal-title":"Jpn J Infect Dis"},{"key":"1339_CR31","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/QAD.0b013e3283365395","volume":"24","author":"A Carbone","year":"2010","unstructured":"Carbone A, Cesarman E, Gloghini A, Drexler HG. Understanding pathogenetic aspects and clinical presentation of primary effusion lymphoma through its derived cell lines. AIDS. 2010;24:479\u201390.","journal-title":"AIDS"},{"key":"1339_CR32","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1046\/j.1365-2141.2000.02006.x","volume":"109","author":"T Inaba","year":"2000","unstructured":"Inaba T, Shimazaki C, Sumikuma T, Okano A, Hatsuse M, Okamoto A, et al. Expression of T-cell-associated antigens in B-cell non-Hodgkin\u2019s lymphoma. Br J Haematol. 2000;109:592\u20139.","journal-title":"Br J Haematol"},{"key":"1339_CR33","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1309\/8B6V-16DJ-UMTB-6LVX","volume":"115","author":"Z Kaleem","year":"2001","unstructured":"Kaleem Z, White G, Zutter MM. Aberrant expression of T-cell-associated antigens on B-cell non-Hodgkin lymphomas. Am J Clin Pathol. 2001;115:396\u2013403.","journal-title":"Am J Clin Pathol"},{"key":"1339_CR34","doi-asserted-by":"crossref","first-page":"7963","DOI":"10.1128\/JVI.71.10.7963-7968.1997","volume":"71","author":"C Blasig","year":"1997","unstructured":"Blasig C, Zietz C, Haar B, Neipel F, Esser S, Brockmeyer NH, et al. Monocytes in Kaposi\u2019s sarcoma lesions are productively infected by human herpesvirus 8. J Virol. 1997;71:7963\u20138.","journal-title":"J Virol"},{"key":"1339_CR35","first-page":"4044","volume":"93","author":"P Monini","year":"1999","unstructured":"Monini P, Colombini S, Sturzl M, Goletti D, Cafaro A, Sgadari C, et al. Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi\u2019s sarcoma. Blood. 1999;93:4044\u201358.","journal-title":"Blood"},{"key":"1339_CR36","doi-asserted-by":"crossref","first-page":"7972","DOI":"10.1128\/JVI.73.10.7972-7980.1999","volume":"73","author":"S Moir","year":"1999","unstructured":"Moir S, Lapointe R, Malaspina A, Ostrowski M, Cole CE, Chun TW, et al. CD40-Mediated induction of CD4 and CXCR4 on B lymphocytes correlates with restricted susceptibility to human immunodeficiency virus type 1 infection: potential role of B lymphocytes as a viral reservoir. J Virol. 1999;73:7972\u201380.","journal-title":"J Virol"},{"key":"1339_CR37","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1182\/blood-2010-12-323659","volume":"118","author":"D Roy","year":"2011","unstructured":"Roy D, Sin SH, Damania B, Dittmer DP. Tumor suppressor genes FHIT and WWOX are deleted in primary effusion lymphoma (PEL) cell lines. Blood. 2011;118:e32\u20139.","journal-title":"Blood"},{"key":"1339_CR38","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1046\/j.1365-2141.2002.03193.x","volume":"116","author":"KS Wilson","year":"2002","unstructured":"Wilson KS, McKenna RW, Kroft SH, Dawson DB, Ansari Q, Schneider NR. Primary effusion lymphomas exhibit complex and recurrent cytogenetic abnormalities. Br J Haematol. 2002;116:113\u201321.","journal-title":"Br J Haematol"},{"key":"1339_CR39","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1128\/JVI.79.2.1244-1251.2005","volume":"79","author":"W Fan","year":"2005","unstructured":"Fan W, Bubman D, Chadburn A, Harrington WJ Jr, Cesarman E, Knowles DM. Distinct subsets of primary effusion lymphoma can be identified based on their cellular gene expression profile and viral association. J Virol. 2005;79:1244\u201351.","journal-title":"J Virol"},{"key":"1339_CR40","doi-asserted-by":"crossref","first-page":"6963","DOI":"10.1158\/0008-5472.CAN-08-0627","volume":"68","author":"AA Mack","year":"2008","unstructured":"Mack AA, Sugden B. EBV is necessary for proliferation of dually infected primary effusion lymphoma cells. Cancer Res. 2008;68:6963\u20138.","journal-title":"Cancer Res"},{"key":"1339_CR41","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1158\/0008-5472.CAN-03-3835","volume":"64","author":"MR Staudt","year":"2004","unstructured":"Staudt MR, Kanan Y, Jeong JH, Papin JF, Hines-Boykin R, Dittmer DP. The tumor microenvironment controls primary effusion lymphoma growth in vivo. Cancer Res. 2004;64:4790\u20139.","journal-title":"Cancer Res"},{"key":"1339_CR42","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1182\/blood-2001-12-0207","volume":"100","author":"M Ito","year":"2002","unstructured":"Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K, et al. NOD\/SCID\/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood. 2002;100:3175\u201382.","journal-title":"Blood"},{"key":"1339_CR43","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s12185-008-0215-z","volume":"88","author":"S Okada","year":"2008","unstructured":"Okada S, Harada H, Ito T, Saito T, Suzu S. Early development of human hematopoietic and acquired immune systems in new born NOD\/Scid\/Jak3null mice intrahepatic engrafted with cord blood-derived CD34\u00a0+\u00a0cells. Int J Hematol. 2008;88:476\u201382.","journal-title":"Int J Hematol"},{"key":"1339_CR44","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1111\/j.1349-7006.2006.00319.x","volume":"97","author":"MZ Dewan","year":"2006","unstructured":"Dewan MZ, Terunuma H, Toi M, Tanaka Y, Katano H, Deng X, et al. Potential role of natural killer cells in controlling growth and infiltration of AIDS-associated primary effusion lymphoma cells. Cancer Sci. 2006;97:1381\u20137.","journal-title":"Cancer Sci"},{"key":"1339_CR45","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1097\/01.pas.0000138177.10829.5c","volume":"28","author":"A Chadburn","year":"2004","unstructured":"Chadburn A, Hyjek E, Mathew S, Cesarman E, Said J, Knowles DM. KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma. Am J Surg Pathol. 2004;28:1401\u201316.","journal-title":"Am J Surg Pathol"},{"key":"1339_CR46","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1525-1578(10)60004-9","volume":"7","author":"A Carbone","year":"2005","unstructured":"Carbone A, Gloghini A, Vaccher E, Cerri M, Gaidano G, Dalla-Favera R, et al. Kaposi\u2019s sarcoma-associated herpesvirus\/human herpesvirus type 8-positive solid lymphomas: a tissue-based variant of primary effusion lymphoma. J Mol Diagn. 2005;7:17\u201327.","journal-title":"J Mol Diagn"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-013-1339-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-013-1339-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-013-1339-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T17:42:34Z","timestamp":1595698954000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-013-1339-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,21]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["1339"],"URL":"https:\/\/doi.org\/10.1007\/s12185-013-1339-3","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,21]]}}}